Nitroglycerin (Glyceryl Trinitrate)

Nitroglycerin, the active ingredient in Nitroglycerin, is an organic nitrate presented as a sublingual tablet for sublingual use. It rapidly dilates coronary and peripheral vessels, reducing myocardial oxygen demand and relieving chest pain associated with angina. The formulation is intended for patients experiencing sudden episodes of angina pectoris or for prophylactic use before exertion.

GNH USA supplies Nitroglycerin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Nitroglycerin is used in the management of cardiovascular conditions where rapid vasodilation is required.

- Acute angina pectoris: provides prompt relief of chest pain by decreasing myocardial oxygen demand. - Prophylaxis of angina attacks: reduces frequency of episodes when taken before physical activity or stress. - Heart failure (off‑label): may improve symptoms by decreasing preload and cardiac workload.

Nitroglycerin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often occurring shortly after administration. - Flushing: warmth and redness of the face or neck. - Dizziness or light‑headedness: due to transient hypotension. - Hypotension: drop in blood pressure, especially when standing. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall leading to syncope. - Methemoglobinemia: elevated methemoglobin causing cyanosis. - Reflex tachycardia: rapid heart rate in response to vasodilation. - Allergic reactions: rash, itching, or anaphylaxis.

When prescribing nitroglycerin, clinicians should consider several safety measures to minimize risks.

- Assess cardiovascular status: evaluate blood pressure and heart rate before initiating therapy. - Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Monitor for tolerance: efficacy may diminish with continuous use; drug‑free intervals may be required. - Educate patients on proper sublingual administration: place tablet under the tongue, allow it to dissolve without swallowing. - Caution in patients with severe anemia or increased intracranial pressure: vasodilation may exacerbate symptoms. - Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Nitroglycerin can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause dangerous hypotension. - Other potent vasodilators (e.g., hydralazine, minoxidil): additive blood pressure lowering effect. - Antihypertensive agents (e.g., beta‑blockers, ACE inhibitors): increase risk of excessive hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance volume depletion and low blood pressure. - Alcohol: can potentiate vasodilatory effects leading to dizziness. - Certain anesthetics (e.g., propofol): may augment hypotensive response.